
Novel Hsp90 ингибитор, exerts мощный antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction
Novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.